Imiglucerase (CEREZYME)

Enzyme replacement therapy (recombinant glucocerebrosidase)

Imiglucerase (CEREZYME)

Forms and strengths
Form: TabletStrength: 400 Units/vial
Print

Indication

  • Imiglucerase is used as long-term enzyme replacement therapy for confirmed type 1 (non-neuronopathic) Gaucher disease.
  • It is also used for the non-neurological manifestations of type 3 (chronic neuronopathic) Gaucher disease, including anemia, low platelet counts, bone disease, and an enlarged liver or spleen.
  • Imiglucerase has not been shown to improve the neurological symptoms of type 3 Gaucher disease.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.